Largest health care pharmaceutical companies by total debt
Borrowings at the end of the latest fiscal year: long-term debt including the part due within a year, plus short-term borrowings. Leases are left out unless the company reports them in one figure with its debt.
AbbVie leads the 35 health care pharmaceutical companies ranked by total debt, at TRY 3.41T, ahead of Pfizer (TRY 3.27T) and Merck & Co (TRY 2.49T). Figures as of 19 Nov 2026, 22:02 UTC, from Yahoo Finance quotes.
Key facts
- Companies ranked
- 35
- First
- AbbVieTRY 3.41T
- Median
- TRY 266.5B
- Combined market value
- TRY 250.75T
- Countries
- 10
- Not ranked
- 26no total debt on file
Market values as of .
All countries▾
Health Care▾
Pharmaceuticals▾
| # | Company | Total debt ↓ | Market cap | Price | Today | 1 year | Price, 30 days | Country |
|---|---|---|---|---|---|---|---|---|
| 1 | AbbVieABBV · Health Care | TRY 3.41T | TRY 25.33T | TRY 14,327.36 | 0.86% down | 25% up | ||
| 2 | PfizerPFE · Health Care | TRY 3.27T | TRY 7.93T | TRY 1,391.60 | 1.85% down | 15% up | ||
| 3 | Merck & CoMRK · Health Care | TRY 2.49T | TRY 16.54T | TRY 6,710.93 | 3.61% down | 45% up | ||
| 4 | Johnson & JohnsonJNJ · Health Care | TRY 2.42T | TRY 32.5T | TRY 13,498.66 | 2.04% down | 34% up | ||
| 5 | Bristol-Myers SquibbBMY · Health Care | TRY 2.28T | TRY 6.03T | TRY 2,947.94 | 2.05% down | 30% up | ||
| 6 | Eli LillyLLY · Health Care | TRY 2.15T | TRY 60.81T | TRY 68,272.50 | 2.29% down | 33% up | ||
| 7 | Takeda PharmaceuticalTAK · Health Care | TRY 1.54T | TRY 3.46T | TRY 1,081.85 | 0.66% up | 51% up | ||
| 8 | AstraZenecaAZN · Health Care | TRY 1.5T | TRY 13.75T | TRY 8,863.52 | 1.87% down | 1% up | ||
| 9 | NovartisNVS · Health Care | TRY 1.45T | TRY 14.43T | TRY 7,641.19 | 2.57% down | 25% up | ||
| 10 | SanofiSNY · Health Care | TRY 1.05T | TRY 5.59T | TRY 2,327.43 | 2.25% down | 4% down | ||
| 11 | Novo NordiskNVO · Health Care | TRY 982B | TRY 8.66T | TRY 1,964.11 | 1.42% down | 17% down | ||
| 12 | GSKGSK · Health Care | TRY 969.4B | TRY 4.84T | TRY 2,416.36 | 1.56% down | 5% up | ||
| 13 | ViatrisVTRS · Health Care | TRY 728.2B | TRY 1.15T | TRY 1,004.54 | 1.97% down | 99% up | ||
| 14 | Abbott LaboratoriesABT · Health Care | TRY 653.3B | TRY 9.09T | TRY 5,248.58 | 0.58% down | 16% down | ||
| 15 | ZoetisZTS · Health Care | TRY 456.9B | TRY 1.66T | TRY 4,082.34 | 5.59% down | 26% down | ||
| 16 | Royalty PharmaRPRX · Health Care | TRY 452.3B | TRY 1.97T | TRY 3,421.91 | 1.38% down | 79% up | ||
| 17 | Jazz PharmaceuticalsJAZZ · Health Care | TRY 270.8B | TRY 766.9B | TRY 11,947.89 | 4.57% down | 41% up | ||
| 18 | GenmabGMAB · Health Care | TRY 266.5B | TRY 1.6T | TRY 2,594.73 | 0.75% up | 70% up | ||
| 19 | Elanco Animal HealthELAN · Health Care | TRY 203B | TRY 664B | TRY 1,328.44 | 1.54% down | 26% up | ||
| 20 | Amneal PharmaceuticalsAMRX · Health Care | TRY 130B | TRY 376.6B | TRY 1,080.84 | 2.24% down | 90% up | ||
| 21 | BridgeBio PharmaBBIO · Health Care | TRY 101.4B | TRY 769.6B | TRY 3,950.46 | 0.22% up | 21% up | ||
| 22 | Regeneron PharmaceuticalsREGN · Health Care | TRY 100.3B | TRY 4.83T | TRY 46,656.65 | 2.35% down | 28% up | ||
| 23 | Ionis PharmaceuticalsIONS · Health Care | TRY 91.6B | TRY 229.1B | TRY 1,375.43 | 0.62% down | 63% down | ||
| 24 | BeOne MedicinesONC · Health Care | TRY 52B | TRY 2.31T | TRY 20,196.96 | 0.97% down | 16% up | ||
| 25 | Ascendis PharmaASND · Health Care | TRY 40.4B | TRY 848.4B | TRY 12,933.74 | 5.32% down | 29% up | ||
| 26 | InsmedINSM · Health Care | TRY 27.6B | TRY 1.6T | TRY 7,299.61 | 20.58% up | 40% down | ||
| 27 | Madrigal PharmaceuticalsMDGL · Health Care | TRY 17.2B | TRY 465.7B | TRY 20,047.39 | 0.34% down | 27% down | ||
| 28 | Legend BiotechLEGN · Health Care | TRY 16.1B | TRY 157.8B | TRY 813.54 | 0.92% down | 41% down | ||
| 29 | CytokineticsCYTK · Health Care | TRY 14.5B | TRY 362.2B | TRY 2,600.29 | 0.27% up | 19% down | ||
| 30 | TG TherapeuticsTGTX · Health Care | TRY 12.4B | TRY 495.5B | TRY 3,278.41 | 1.88% down | 117% up | ||
| 31 | Cogent BiosciencesCOGT · Health Care | TRY 11.3B | TRY 243.9B | TRY 1,401.71 | 0.25% down | 20% down | ||
| 32 | Dr. Reddy's LaboratoriesRDY · Health Care | TRY 9.8B | TRY 624.7B | TRY 749.36 | 1.00% down | 8% up | ||
| 33 | Axsome TherapeuticsAXSM · Health Care | TRY 9.5B | TRY 360.6B | TRY 6,855.95 | 1.25% up | 6% down | ||
| 34 | Rhythm PharmaceuticalsRYTM · Health Care | TRY 5.5B | TRY 409.2B | TRY 5,901.94 | 1.88% down | 18% up | ||
| 35 | Definium TherapeuticsDFTX · Health Care | TRY 2.1B | TRY 203.9B | TRY 1,489.63 | 1.24% up | 168% up |
Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration; annual figures from the reports companies file with the SEC.
Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Total debt is from each company's latest annual report filed with the SEC (collected 2026-11-12); a company that reports in another currency is converted to US dollars at the exchange rate of that day, not of the period. Total debt is assembled from each company's debt lines and is the least complete of these figures: some companies tag part of their borrowings in ways it misses. Sums are converted from US dollars at today's exchange rate (1 USD = 50.5303 TRY). 26 companies have no total debt on file and are not ranked here.
Questions and answers
Which health care pharmaceutical companies rank first by total debt?
AbbVie (TRY 3.41T), Pfizer (TRY 3.27T) and Merck & Co (TRY 2.49T) are the top three of the 35 health care pharmaceutical companies ranked by total debt as of 19 Nov 2026, 22:02 UTC.
How many health care pharmaceutical companies are in this ranking?
35 are ranked by total debt. 26 more have no total debt on file and are left out rather than ranked at zero.
What are these health care pharmaceutical companies worth together?
The 35 health care pharmaceutical companies ranked by total debt have a combined market value of TRY 250.75T as of 19 Nov 2026, 22:02 UTC.
What does ranking by total debt measure?
Borrowings at the end of the latest fiscal year: long-term debt including the part due within a year, plus short-term borrowings. Leases are left out unless the company reports them in one figure with its debt.
Learn how this ranking works
All markets guides →- Altman Z-score: formula, zones and where it fails
The Altman Z-score is a weighted sum of five financial ratios that Edward Altman fitted in 1968 to separate companies that went bankrupt from those that did not. Funkfolio reads above 2.99 as the safe zone, below 1.81 as the distress zone, and between them a grey zone. It does not suit banks or insurers.
- Market cap vs enterprise value: what is the difference?
Market capitalization is the value of a company's shares. Enterprise value is market cap plus debt, minus cash: roughly what it would cost to buy the whole business and settle its borrowings. Two companies with the same $50 billion market cap can have very different enterprise values if one owes $20 billion and the other holds $20 billion in cash.
- How an ETF's size is measured: AUM, NAV and creation units
An ETF's size is usually measured by its assets under management (AUM), the fund's net assets: everything it holds minus what it owes. That equals net asset value per share times shares outstanding. AUM grows when the holdings rise in value and when large institutions create new shares, and shrinks when they redeem them.
Cite this page
Funkfolio, “Largest health care pharmaceutical companies by total debt”, data as of 19 November 2026. https://funkfolio.com/companies/category/pharmaceuticals?sector=health-care&by=total-debt
Underlying data: Yahoo Finance; SEC EDGAR.